Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BWAY Brainsway	$15.20 +1.4%	$12.43	$7.06 ▼ $15.61	$287.31M	1.42	70,647 shs	72,373 shs
OM Outset Medical	$14.20 +3.9%	$17.29	$5.85 ▼ $25.35	$252.28M	2.14	325,273 shs	280,746 shs
STIM Neuronetics	$3.40 +0.6%	$3.78	$0.52 ▼ $5.92	$224.82M	1.78	1.39 million shs	1.90 million shs
TELA TELA Bio	$1.77 +2.9%	$1.84	$0.86 ▼ $3.26	$70.12M	0.93	98,506 shs	97,402 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BWAY Brainsway	0.00%	+17.10%	+28.38%	+41.66%	+91.19%
OM Outset Medical	0.00%	+6.85%	-19.36%	-20.89%	+37.20%
STIM Neuronetics	0.00%	+1.80%	-23.60%	-14.79%	+242.53%
TELA TELA Bio	0.00%	+12.03%	-9.23%	+22.92%	-41.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BWAY Brainsway	3.1487 of 5 stars	2.5	5.0	3.2	0.8	1.9
OM Outset Medical	1.487 of 5 stars	3.5	2.0	1.9	0.0	0.0
STIM Neuronetics	1.5469 of 5 stars	3.5	1.0	1.1	0.8	0.6
TELA TELA Bio	3.0042 of 5 stars	3.3	4.0	3.0	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BWAY Brainsway	3.00	Buy	$18.00	18.42% Upside
OM Outset Medical	3.00	Buy	$24.67	73.71% Upside
STIM Neuronetics	3.00	Buy	$7.00	105.88% Upside
TELA TELA Bio	2.50	Moderate Buy	$4.50	154.24% Upside

Current Analyst Ratings Breakdown

Latest TELA, BWAY, OM, and STIM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/19/2025	OM Outset Medical	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sector Perform ➝ Sector Perform	$22.00
8/14/2025	BWAY Brainsway	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$16.00 ➝ $17.00
8/14/2025	BWAY Brainsway	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$15.00 ➝ $19.00
8/7/2025	OM Outset Medical	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$21.00 ➝ $22.00
8/6/2025	STIM Neuronetics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$8.00 ➝ $7.00
7/14/2025	OM Outset Medical	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$37.00
6/9/2025	BWAY Brainsway	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$16.00

(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BWAY Brainsway	$41.02M	7.00	$0.25 per share	60.96	$3.31 per share	4.59
OM Outset Medical	$113.69M	2.22	N/A	N/A	$7.49 per share	1.90
STIM Neuronetics	$74.89M	3.00	N/A	N/A	$0.57 per share	5.96
TELA TELA Bio	$69.30M	1.01	N/A	N/A	$0.72 per share	2.46

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BWAY Brainsway	$2.92M	$0.26	58.46	95.00	N/A	11.60%	8.97%	5.65%	11/11/2025 (Estimated)
OM Outset Medical	-$127.98M	-$20.29	N/A	∞	N/A	-82.06%	-97.17%	-32.84%	11/5/2025 (Estimated)
STIM Neuronetics	-$43.71M	-$1.13	N/A	N/A	N/A	-43.47%	-156.36%	-35.69%	11/11/2025 (Estimated)
TELA TELA Bio	-$37.84M	-$1.12	N/A	N/A	N/A	-54.12%	-329.48%	-57.34%	11/6/2025 (Estimated)

Latest TELA, BWAY, OM, and STIM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	Q2 2025	BWAY Brainsway	$0.07	$0.10	+$0.03	$0.10	$12.34 million	$12.63 million
8/11/2025	Q2 2025	TELA TELA Bio	-$0.18	-$0.22	-$0.04	-$0.22	$20.67 million	$20.20 million
8/5/2025	Q2 2025	STIM Neuronetics	-$0.08	-$0.15	-$0.07	-$0.15	$36.80 million	$38.11 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BWAY Brainsway	N/A	N/A	N/A	N/A	N/A
OM Outset Medical	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	N/A	N/A	N/A	N/A	N/A
TELA TELA Bio	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BWAY Brainsway	N/A	3.51	3.34
OM Outset Medical	0.63	7.47	6.05
STIM Neuronetics	1.76	2.02	1.84
TELA TELA Bio	4.14	3.19	2.59

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BWAY Brainsway	30.11%
OM Outset Medical	N/A
STIM Neuronetics	53.59%
TELA TELA Bio	94.35%

Insider Ownership

Company	Insider Ownership
BWAY Brainsway	19.00%
OM Outset Medical	2.40%
STIM Neuronetics	9.80%
TELA TELA Bio	4.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BWAY Brainsway	120	18.90 million	15.31 million	Not Optionable
OM Outset Medical	520	17.77 million	17.34 million	Not Optionable
STIM Neuronetics	180	66.12 million	59.65 million	Optionable
TELA TELA Bio	120	39.62 million	37.75 million	Optionable

TELA, BWAY, OM, and STIM Headlines

Recent News About These Companies

TELA Bio (NASDAQ:TELA) Shares Down 2.9% - Here's What Happened

August 23 at 3:18 AM | marketbeat.com

Aroa Biosurgery Reports Strong Growth and Expands Product Range Amid Market Challenges

August 20, 2025 | msn.com

Tela Bio reports Q2 EPS (22c), consensus (19c)

August 13, 2025 | msn.com

TELA Bio (NASDAQ:TELA) Issues Earnings Results

August 12, 2025 | marketbeat.com

Tela Bio backs FY25 revenue view $85M-$88M, consensus $86.05M

August 12, 2025 | msn.com

Tela Bio reiterates $85M–$88M 2025 revenue target as international expansion accelerates

August 12, 2025 | msn.com

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

August 11, 2025 | zacks.com

TELA Bio, Inc. (TELA) Q2 2025 Earnings Call Transcript

August 11, 2025 | seekingalpha.com

TELA Bio Reports Second Quarter 2025 Financial Results

August 11, 2025 | globenewswire.com

TELA Bio Inc (TELA) Q2 2025 Earnings Report Preview: What To Expect

August 10, 2025 | finance.yahoo.com

TELA Bio Awards Inducement Equity Grants to New Employees

August 10, 2025 | msn.com

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 8, 2025 | globenewswire.com

TELA Bio (TELA) Expected to Announce Quarterly Earnings on Monday

August 5, 2025 | marketbeat.com

TELA Bio (NASDAQ:TELA) Trading 4.2% Higher - Time to Buy?

July 30, 2025 | marketbeat.com

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

July 23, 2025 | globenewswire.com

TELA Bio to Announce Second Quarter 2025 Financial Results

July 21, 2025 | globenewswire.com

TELA Bio, Inc. (TELA) Latest Stock News & Headlines - Yahoo Finance

July 19, 2025 | finance.yahoo.com

Breakeven On The Horizon For TELA Bio, Inc. (NASDAQ:TELA)

July 3, 2025 | finance.yahoo.com

TELA Bio Welcomes Jim Hagen with Strategic Equity Grant

June 9, 2025 | msn.com

TELA Bio, Inc.: TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 7, 2025 | finanznachrichten.de

TELA Bio, Inc. Grants Inducement Equity Awards to New Senior Vice President Jim Hagen

June 6, 2025 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TELA, BWAY, OM, and STIM Company Descriptions

Brainsway NASDAQ:BWAY

$15.20 +0.21 (+1.40%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$15.14 -0.06 (-0.39%)

As of 08/22/2025 05:57 PM Eastern

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Outset Medical NASDAQ:OM

$14.20 +0.53 (+3.88%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$14.18 -0.02 (-0.18%)

As of 08/22/2025 05:19 PM Eastern

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Neuronetics NASDAQ:STIM

$3.40 +0.02 (+0.59%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$3.42 +0.02 (+0.59%)

As of 08/22/2025 07:43 PM Eastern

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

TELA Bio NASDAQ:TELA

$1.77 +0.05 (+2.91%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$1.78 +0.01 (+0.56%)

As of 08/22/2025 04:10 PM Eastern

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time